Multimodal in vivo imaging and blood monitoring of intrinsic and extrinsic apoptosis

Molecular Therapy

Volumn 19, Issue 6, 2011, Pages 1090-1096

  Niers, Johanna M ^a,b   Kerami, Mariam ^a,b   Pike, Lisa ^a   Lewandrowski, Grant ^a   Tannous, Bakhos A ^a,c  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^c HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ASPARTIC ACID; CASPASE 3; GLUTAMIC ACID; GREEN FLUORESCENT PROTEIN; HYBRID PROTEIN; LUCIFERASE; VALINE;

AMINO TERMINAL SEQUENCE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; APOPTOSIS; ARTICLE; BIOLOGICAL MONITORING; BIOLUMINESCENCE; BIOSENSOR; CELL VACUOLE; CONTROLLED STUDY; CYTOPLASM; ENDOPLASMIC RETICULUM; ENZYME ACTIVATION; EX VIVO STUDY; GOLGI COMPLEX; HUMAN; HUMAN CELL; IMAGING SYSTEM; MOUSE; NONHUMAN; PROTEIN CLEAVAGE; PROTEIN FOLDING; PROTEIN PROTEIN INTERACTION; PROTEIN SECRETION; SECRETORY PATHWAY;

ANIMALIA;

EID: 79957895050     PISSN: 15250016     EISSN: 15250024     Source Type: Journal    
DOI: 10.1038/mt.2011.17     Document Type: Article

References (24)

1. Budihardjo, I, Oliver, H, Lutter, M, Luo, X and Wang, X (1999). Biochemical pathways of caspase activation during apoptosis. Annu Rev Cell Dev Biol 15: 269-290. (Pubitemid 32250377)
2. Fesik, SW (2005). Promoting apoptosis as a strategy for cancer drug discovery. Nat Rev Cancer 5: 876-885. (Pubitemid 41746032)
3. Mofftt, KL, Martin, SL and Walker, B (2010). Proteases implicated in apoptosis: old and new. J Pharm Pharmacol 62: 563-576.
4. Blankenberg, FG (2009). Apoptosis imaging: anti-cancer agents in medicinal chemistry. Anticancer Agents Med Chem 9: 944-951.
5. Fulda, S and Debatin, KM (2004). Signaling through death receptors in cancer therapy. Curr Opin Pharmacol 4: 327-332. (Pubitemid 38987057)
6. Meng, XW, Lee, SH and Kaufmann, SH (2006). Apoptosis in the treatment of cancer: a promise kept? Curr Opin Cell Biol 18: 668-676. (Pubitemid 44692481)
7. D'Atri, S, Tentori, L, Lacal, PM, Graziani, G, Pagani, E, Benincasa, E et al. (1998). Involvement of the mismatch repair system in temozolomide-induced apoptosis. Mol Pharmacol 54: 334-341. (Pubitemid 28368823)
8. Günther, W, Pawlak, E, Damasceno, R, Arnold, H and Terzis, AJ (2003). Temozolomide induces apoptosis and senescence in glioma cells cultured as multicellular spheroids. Br J Cancer 88: 463-469. (Pubitemid 36308160)
9. Boehrer, S, Nowak, D, Hoelzer, D, Mitrou, PS and Chow, KU (2006). The molecular biology of TRAIL-mediated signaling and its potential therapeutic exploitation in hematopoietic malignancies. Curr Med Chem 13: 2091-2100. (Pubitemid 44132601)
10. Fulda, S and Debatin, KM (2004). Modulation of TRAIL signaling for cancer therapy. Vitam Horm 67: 275-290. (Pubitemid 39753668)
11. Laxman, B, Hall, DE, Bhojani, MS, Hamstra, DA, Chenevert, TL, Ross, BD et al. (2002). Noninvasive real-time imaging of apoptosis. Proc Natl Acad Sci USA 99: 16551-16555. (Pubitemid 36034010)
12. Ray, P, De, A, Patel, M and Gambhir, SS (2008). Monitoring caspase-3 activation with a multimodality imaging sensor in living subjects. Clin Cancer Res 14: 5801-5809.
13. Edgington, LE, Berger, AB, Blum, G, Albrow, VE, Paulick, MG, Lineberry, N et al. (2009). Noninvasive optical imaging of apoptosis by caspase-targeted activity-based probes. Nat Med 15: 967-973.
14. Tannous, BA, Kim, DE, Fernandez, JL, Weissleder, R and Breakefeld, XO (2005). Codon-optimized Gaussia luciferase cDNA for mammalian gene expression in culture and in vivo. Mol Ther 11: 435-443. (Pubitemid 40277320)
15. Tannous, BA (2009). Gaussia luciferase reporter assay for monitoring biological processes in culture and in vivo. Nat Protoc 4: 582-591.
16. Wurdinger, T, Badr, C, Pike, L, de Kleine, R, Weissleder, R, Breakefeld, XO et al. (2008). A secreted luciferase for ex vivo monitoring of in vivo processes. Nat Methods 5: 171-173. (Pubitemid 351181745)
17. Maguire, CA, Deliolanis, NC, Pike, L, Niers, JM, Tjon-Kon-Fat, LA, Sena-Esteves, M et al. (2009). Gaussia luciferase variant for high-throughput functional screening applications. Anal Chem 81: 7102-7106.
18. Badr, CE, Wurdinger, T and Tannous, BA (2010). Functional Drug Screening Assay Reveals Potential Glioma Therapeutics. Assay Drug Dev Technol (epub ahead of print).
19. Badr, CE, Hewett, JW, Breakefeld, XO and Tannous, BA (2007). A highly sensitive assay for monitoring the secretory pathway and ER stress. PLoS ONE 2: e571.
20. Higuchi, M, Honda, T, Proske, RJ and Yeh, ET (1998). Regulation of reactive oxygen species-induced apoptosis and necrosis by caspase 3-like proteases. Oncogene 17: 2753-2760. (Pubitemid 28554234)
21. Niquet, J, Allen, SG, Baldwin, RA and Wasterlain, CG (2004). Evidence of caspase-3 activation in hyposmotic stress-induced necrosis. Neurosci Lett 356: 225-227. (Pubitemid 38186692)
22. Sena-Esteves, M, Tebbets, JC, Steffens, S, Crombleholme, T and Flake, AW (2004). Optimized large-scale production of high titer lentivirus vector pseudotypes. J Virol Methods 122: 131-139. (Pubitemid 39470183)
23. Palmieri, D, Bronder, JL, Herring, JM, Yoneda, T, Weil, RJ, Stark, AM et al. (2007). Her-2 overexpression increases the metastatic outgrowth of breast cancer cells in the brain. Cancer Res 67: 4190-4198. (Pubitemid 46815065)
24. Chung, E, Yamashita, H, Au, P, Tannous, BA, Fukumura, D and Jain, RK (2009). Secreted Gaussia luciferase as a biomarker for monitoring tumor progression and treatment response of systemic metastases. PLoS ONE 4: e8316